Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 36.6T | 37.7T | 36.9T | 37.9T |
| Cost of revenue | 11.7T | 13.1T | 12.0T | 11.4T |
| Gross profit | 25.0T | 24.7T | 25.0T | 26.4T |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 6.1T | 6.3T | 6.0T | 7.6T |
| Other operating expenses | 76B | — | — | — |
| Operating income | 10.1T | 10.3T | 10.6T | 10.4T |
| Non operating interest income | ||||
| Income | 420B | 347B | 315B | 370B |
| Expense | 1.3T | 1.4T | 1.4T | 1.2T |
| Other income expense | 385B | 250B | 179B | 225B |
| Pretax income | 9.6T | 9.5T | 9.7T | 9.8T |
| Tax provision | 2.0T | 1.8T | 2.1T | 2.2T |
| Net income | 7.6T | 7.7T | 7.6T | 7.6T |
| Basic EPS | — | — | — | — |
| Diluted EPS | — | — | — | — |
| Basic average shares | — | — | — | — |
| Diluted average shares | — | — | — | — |
| EBITDA | 18.6T | 18.4T | 19.1T | 19.4T |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -1.8T | -1.8T | -1.7T | -1.9T |
| Preferred stock dividends | — | — | — | — |